{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:46:16Z","timestamp":1747154776195,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.amjcard.2024.08.003","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:23:50Z","timestamp":1722961430000},"page":"79-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rethinking the Role of Co-morbidities in Transthyretin Cardiac Amyloidosis: Cinderella or Princess? The Case of Anemia and Iron Deficiency"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-0961","authenticated-orcid":false,"given":"Giuseppe D.","family":"Sanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Milani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Palladini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.08.003_bib0001","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC Expert Consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology solution set oversight committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0002","doi-asserted-by":"crossref","unstructured":"Milani P, Fabris F, Mussinelli R, Sanna GD, Basset M, Benvenuti P, Bellofiore C, Nanci M, Nuvolone M, Attanasio A, Guida G, Perlini S, Foli A, Merlini G, Palladini G. Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis [published online July 11, 2024]. Amyloid doi: 10.1080\/13506129.2024.2374904.","DOI":"10.1080\/13506129.2024.2374904"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0003","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0004","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjcard.2024.07.020","article-title":"Impact of anemia on mortality and morbidity in transthyretin amyloid cardiomyopathy","volume":"228","author":"Wardhere","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0006","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ehf2.13818","article-title":"Prevalence and determinants of iron deficiency in cardiac amyloidosis","volume":"9","author":"Jobb\u00e9-Duval","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2023.100063","article-title":"The impact of iron deficiency on disease severity and myocardial function in cardiac amyloidosis","volume":"11","author":"Martens","year":"2024","journal-title":"Am J Med Open"},{"issue":"suppl K","key":"10.1016\/j.amjcard.2024.08.003_bib0008","article-title":"960 Early onset of subtle liver damage in TTR amyloidosis patients treated with tafamidis","volume":"24","author":"Agbariah","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0009","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.003_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jchf.2022.10.004","article-title":"Potential interactions when prescribing SGLT2 inhibitors and intravenous iron in combination in heart failure","volume":"11","author":"Packer","year":"2023","journal-title":"JACC Heart Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T04:17:07Z","timestamp":1729570627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924005769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":10,"alternative-id":["S0002914924005769"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.003","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking the Role of Co-morbidities in Transthyretin Cardiac Amyloidosis: Cinderella or Princess? The Case of Anemia and Iron Deficiency","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.07.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}